Skip to main content
BMJ Case Reports logoLink to BMJ Case Reports
. 2019 Sep 30;12(9):e230490. doi: 10.1136/bcr-2019-230490

Streptococcus pyogenes peritonitis: a rare, lethal imitator of appendicitis

Matthew Johnson 1, Ashley Bartscherer 1, Ellis Tobin 2, Marcel Tafen 1
PMCID: PMC6768339  PMID: 31570352

Abstract

Streptococcus pyogenes is a common cause of infection. Since 2010, the Centers for Disease Control has noted a 24% rise in invasive S. pyogenes infections with a mortality rate of 10%. We present a case series and review of the English literature. Two patients presented with findings concerning for appendicitis, each underwent laparoscopic appendectomies. Both had diffuse peritoneal inflammation without appendicitis, cultures grew S. pyogenes and both recovered with appropriate antibiotics. Thirty cases were identified in a review of the English literature. The average age was 27 years, 75% were in women, 9% were immunocompromised, 15% had rashes and 88% underwent surgical intervention. Previous work identified female gender, immunosuppression and preceding varicella infection as risk factors for invasive S. pyogenes. Given the similarities to appendicitis, early suspicion can influence antibiotic therapy and possibly improve outcomes.

Keywords: general surgery, infectious diseases

Background

Streptococcus pyogenes is a gram-positive coccus harbouring the Lancefield group A antigen that causes a wide variety of potentially lethal infections.1 Invasive S. pyogenes infections include sepsis, empyema, endocarditis, osteomyelitis, necrotising fasciitis, surgical wound infections, endometritis and peritonitis.2 Between the years 2010 and 2015, the Centers for Disease Control reported an approximately 20% increase in invasive S. pyogenes infections and an attributable mortality rate of 10%.3–5 Only 5% of invasive S. pyogenes infections were due to primary peritonitis in a nationwide review of paediatric invasive S. pyogenes cases in Finland.6 Without a high index of suspicion for S. pyogenes infections, clinicians may be more likely to misdiagnose the patient and delay crucial antimicrobial therapy. The study was approved by the institutional review board and reviewed two patients with primary S. pyogenes peritonitis treated at a tertiary academic medical centre along with 30 cases presented in the literature in an attempt to better define this rare, poorly understood disease process.

Case presentation

Case 1

A 14-year-old male patient presented to an outside hospital with 3 days of worsening right lower quadrant pain and associated nausea, vomiting and subjective fever. His examination was significant for diffuse abdominal tenderness with rebound and guarding, worst in the Right lower Quadrant (RLQ). On hospital day 1, the patient was noted to have a fever of 38°C and leucocytosis (25x109/L) with 46% bands. An initial urinalysis was unremarkable. A CT abdomen and pelvis demonstrated a 9 mm rim enhanced, fluid filled appendix and small amount of free pelvic fluid. The patient was started empirically on ertapenem in preparation for the operating room. On hospital day 2, the patient underwent a laparoscopic appendectomy which revealed hyperaemic bowel and grossly purulent free fluid in the abdomen and pelvis as well as a normal appearing appendix that was removed. The pathology report showed minimal amount of grey fibrinous exudate that may be consistent with acute appendicitis. Nineteen hours after the operation, the patient met criteria for severe sepsis: febrile to 38°C, leucocytosis (white cell count 17.4x109/L) and acute kidney injury (creatinine increased from 1.0 to 1.8 mg/dL) with oliguria. Gram stain of peritoneal fluid found gram-positive cocci in round pairs and chains, Remel Streptex Rapid Latex Agglutination Test identified the isolate as containing the Lancefield group A antigen and no further testing was completed. The patient was transferred to our centre’s paediatric intensive care unit and clindamycin was added to the antibiotic regimen. The formal culture was sensitive to ampicillin, penicillin, ceftriaxone, clindamycin, erythromycin, vancomycin, linezolid and levofloxacin.

Case 2

A 52-year-old female patient presented to the emergency department with 3 days of right lower quadrant abdominal pain associated with nausea, vomiting, poor oral intake, fever of 38.9°C and leucocytosis (20.9x109/L) with 84% neutrophils. Her abdomen was tender to palpation at McBurney’s point with no rebound tenderness or guarding. In the emergency department there was initial concern for urinary tract infection based on a urinalysis that showed 2+ leucocyte esterase and 10–20 white cell count per high-powered field. Oral sulfamethoxazole/trimethoprim was initiated empirically. A CT abdomen and pelvis was obtained for evaluation of persistent abdominal pain, and it revealed a 1 cm dilated, fluid filled appendix and an 8.5×8.5 cm heterogenous pelvic mass at the level of the cervix. Appendicitis with abscess was suspected, and she was taken to the operating room on hospital day 2 for laparoscopic evaluation. Inspection of the pelvis showed an inflamed right ovary with mucopurulent fluid involving the tip of the appendix, which had a normal appearing base. The appendix was removed, and a further inspection showed no extension of the inflammation beyond the lower right quadrant. Pelvic fullness, corresponding to the large pelvic mass seen on CT, was appreciated in the retroperitoneum low in the pelvis, contiguous with the cervix. Gynaecology evaluated the patient in the operating room and determined that the mass was inflammation of the right ovary and fallopian tube secondary to appendicitis. A drain was placed in the pelvis, the abdomen was irrigated and closed. The pathology report showed chronic active periappendicitis, with no primary appendiceal inflammation. Peritoneal fluid and endocervical cultures showed gram-positive cocci in pairs and chains. Gynaecology had noted a normal cervix on their initial evaluation, and the infection was determined to be unrelated to cervicitis. Postoperative antibiotics initially consisted of piperacillin–tazobactam and linezolid. She was transitioned to ampicillin–sulbactam on hospital day 4 at the recommendation of infectious disease consultant after identification of S. pyogenes was confirmed via the Bruker Biotyper matrix-assisted laser desorption/ionization time of flight (MALDI-TOF) system (MALDI identification score: 2.415) with secondary confirmation using the pyrrolidonyl arylamidase test. However, no formal sensitivity testing was conducted on either peritoneal or endocervical cultures.

Outcome and follow-up

Both patients did well with focused antibiotics, the young man in our first case recovered after his tumultuous course and was discharged on hospital day 5 with a 5-day course of levofloxacin. The middle-aged woman in our second case did well with the tailored antibiotic regimen, she was treated in the hospital for 6 days and then discharged on hospital day 7 with an 8-day course of amoxicillin–clavulanic acid. Both patients are doing well as of the writing of this report with no complications related to their infection or operation.

Discussion

Literature review

We completed a review of the English literature as of March 2018 in the NCBI PubMed database using the search terms ‘Streptococcus pyogenes OR Group A Streptococcus AND primary peritonitis’. Additional cases were found by cross-referencing the references of the previously identified papers. Cases were excluded if there was a clearly identified primary aetiology of peritonitis prior to diagnosis such as peritoneal dialysis, hepatic ascites or known pelvic inflamatory disease. A total of 30 cases were identified and 32 total cases were reviewed including our two patients (table 1). Patient demographics and common findings are outlined in table 2.

Table 1.

Published case studies on primary Streptococcus pyogenes peritonitis

Case study Age and gender Suspected diagnosis Rash Imaging Surgery Initial antibiotics Follow-up antibiotics
Woods and Mason19 15-year-old female No CT: thickened small bowel and ascending colon, small amount of free fluid in pelvis Laparotomy Clindamycin None
Moskovitz et al 20 39-year-old female Appendicitis No None Laparoscopy Levofloxacin and metronidazole Ceftriaxone and ampicillin–sulbactam
Tufariello et al 21 27-year-old male Appendicitis No CT: dilated blind RLQ loop of bowel consistent with appendicitis Appendectomy Cefotetan Vancomycin, ampicillin, metronidazole and gentamicin
Sanchez and Lancaster22 34-year-old male No CT: normal Laparoscopy Piperacillin–tazobactam Penicillin G and clindamycin
Gillespie et al 23 3-year-old female No X-ray: ileus Laparotomy Ampicillin, gentamicin and clindamycin Penicillin G and clindamycin
Kanetake et al 24 40-year-old male Appendicitis Yes CT: distention of the small intestine Laparotomy Unspecified None
Dann et al 12 8-year-old female Appendicitis with partial/early small bowel obstruction No CT: intraperitoneal fluid, dilated small bowel loops, peritoneal enhancement, could not identify normal appendix Laparotomy Unspecified None
Dann et al 12 6-year-old female Primary bacterial peritonitis No CT: complex ascites with diffuse peritoneal enhancement, no appendicitis Laparoscopy Unspecified None
Dumas et al 25 51-year-old female Appendicitis No Chest X-ray: negative; abdominopelvic scan: 10 cm diameter appendix Coelio-surgery Ceftriaxone and metronidazole Penicillin G and ceftriaxone
 Sewery and Bryant26 7-month-old female Small bowel obstruction No Abdominal radiography: dilated duodenum with edematous folds and termination of flow Laparotomy Ceftriaxone and metronidazole Penicillin G
Tilanus et al 27 39-year-old female Pelvic inflammatory disease Yes CT: thickened right psoas muscle surrounded by fatty infiltration and a large amount of free fluid in the peritoneal cavity None Amoxicillin–clavulanic acid, clindamycin and gentamicin Benzylpenicillin and clindamycin
Saha et al 28 23-year-old female Appendicitis No CT: left sided adnexal mass with moderate amount of free fluid Laparotomy Unspecified None
Haap et al 29 27-year-old male Bowel obstruction No US: fluid in Morrison’s pouch; gallstones CT: edematous alteration of small intestine; segmental colitis of transverse colon and perirectal oedema Laparotomy Piperacillin–tazobactam ciprofloxacin and metronidazole None
Legras et al 30 32-year-old female Urinary tract infection No CT: free peritoneal fluid, most abundant in the pelvis Laparotomy Gentamicin and ofloxacin Ceftriaxone, metronidazole and levofloxacin
Demitrack31 3-year-old female Appendicitis Yes CT: diffuse ileus and ascites Appendectomy Ampicillin, gentamicin and clindamycin Penicillin G and clindamycin
Holden et al 32 14-year-old female Appendicitis No US: no appendix visualisation Laparoscopy Metronidazole and ciprofloxacin Meropenem and clindamycin
Preece et al 33 17-year-old female Appendicitis No Unknown Laparoscopy Benzylpenicillin Doxycycline, metronidazole and phenoxymethylpenicillin
Park et al 34 29-year-old female Appendicitis No CT: edematous swelling of intestinal wall and ascites with peritoneal enhancement Laparoscopy Ampicillin–sulbactam Penicillin G and metronidazole
Cheung et al 35 16-month-old male Small bowel obstruction No CT: small bowel obstruction and large ascites Laparotomy Ampicillin, gentamicin and metronidazole Penicillin G and clindamycin
 Nogami et al 36 40-year-old female Adverse reaction to chemotherapy No CT: ascites, no perforation Laparotomy Meropenem and vancomycin Ampicillin–sulbactam
Patel et al 37 6-year-old male Gastroenteritis, perforated appendix, peritonitis No Chest X-ray: negative Laparotomy Cefuroxime, gentamicin and metronidazole None
Filan and Abbas38 7-year-old male Gastroenteritis, appendicitis No CT: free fluid and two intra-abdominal abscesses Laparoscopy Piperacillin–tazobactam None
Min et al 39 51-year-old female Gastritis No CT: diffusely distended and thickened whole stomach with intraperitoneal fluid Laparotomy Unspecified None
Kaneko et al 40 28-year-old female No CT: edematous swelling of the intestinal wall with dense fat infiltrations in the pelvic cavity but no marked free air or ascites None Vancomycin and piperacillin–tazobactam Penicillin G and clindamycin
 Abellan Morcillo et al 41 60-year-old female No CT: minimal amount of free intraperitoneal fluid with no other findings Laparoscopy Amoxicillin–clavulanic acid Clindamycin and a third-generation cephalosporin
Yokoyama et al 42 40-year-old female Intra-abdominal haemorrhage or formation of a pelvic abscess Yes CT: uterine fibroids, ascites and thickening of the peritoneum Laparotomy Azithromycin Meropenem
Chomton et al 43 10-year-old female Primary peritonitis and toxic shock syndrome Yes Abdominal ultrasound: free peritoneal fluid Laparoscopy Cefazolin, cefotaxime and clindamycin None
 Iitaka et al 44 26-year-old female Peritonitis No CT: large amount of free fluid in the peritoneal cavity consistent with a peritonitis; no free air Paracentesis Meropenem Piperacillin–tazobactam and clindamycin
Iwata and Iwase45 66-year-old female Enteritis of unknown origin No CT: small bowel dilation without ischaemic signs and mild pelvic ascites None Meropenem Ampicillin–sulbactam and clindamycin
Ledger46 46-year-old female Appendicitis, ectopic pregnancy and enteritis No CT: intra-abdominal stranding consistent with peritonitis None Benzylpenicillin None
 Case 1 14-year-old male Appendicitis No CT: free fluid in the pelvis suspicious for early appendicitis Laparotomy Ertapenem Piperacillin–tazobactam
 Case 2 52-year-old female Appendicitis No CT: 1 cm dilated, fluid filled appendix and a large heterogenous pelvic mass at the level of the cervix Laparotomy Sulfamethoxazole– trimethoprim Piperacillin–tazobactam and linezolid

Table 2.

Characteristics and demographics of the literature review

Average age 27
Rash 5 15%
Female gender 24 75%
Immunocompromised status 3 9%
HIV 2 6%
Chemotherapy 1 3%
Underwent surgical intervention 28 88%
Total cases 32

Discussion

Primary bacterial peritonitis is a rare cause of acute abdomen and can be difficult to diagnose because it presents sporadically in previously healthy individuals with symptoms similar to those of appendicitis.7 Multiple global surveillance studies have indicated that invasive S. pyogenes infections have been increasing in incidence over the past two decades.4 6 8–10 Invasive S. pyogenes infections can cause significant morbidity and mortality, with a mean case fatality in affluent countries ranging from 8% to 16%, rates similar to those caused by invasive meningococcal disease.8

Since S. pyogenes is not a part of the normal gastrointestinal flora, it is rarely a cause of intra-abdominal infection. However, our literature review revealed multiple case reports documenting a primary peritoneal S. pyogenes infection, many with symptoms mimicking that of appendicitis, as seen in table 1. Due to the similar symptoms shared between S. pyogenes peritonitis and appendicitis, distinguishing between the two can be difficult. Since the literature suggests that patients with appendicitis should undergo surgery within the first 72 hours of symptom presentation to minimise the risk of perforation, there is a narrow window of time to identify S. pyogenes infection and distinguish it from appendicitis.11 Previous work has highlighted the importance of proper radiological interpretation of CT scans and ultrasounds to prevent unnecessary surgical intervention in this patient population.12

We performed a literature review of S. pyogenes peritonitis evaluating medical history, suspected diagnosis, rash, imaging findings and surgical intervention. Several cases have illustrated that S. pyogenes peritonitis can originate from the appendix itself; however, there are also many reported cases, similar to our two patients, in which the aetiology is unclear. Review of the literature has identified female gender, immunosuppression and preceding varicella infection as risk factors for developing primary S. pyogenes peritonitis.6 13 14 It has been hypothesised that women are at greater risk due to retrograde passage of organisms through the genital tract.7 This is a possible aetiology in our second case. However, one of our patients and approximately a quarter of the cases identified in the literature were men. Additionally, a number of women did not have associated genitourinary or gynaecologic sources of S. pyogenes. There must be additional mechanisms leading to the peritoneal invasion by S. pyogenes, although these are not clear based on our review.

Immunosuppression, specifically HIV infection, appears to be a risk factor for invasive S. pyogenes disease in adults. Several case reports have documented primary S. pyogenes peritonitis in immunocompromised patients. One case report has documented primary S. pyogenes peritonitis in a 15-year-old female patient with HIV, in which the appendix was normal on surgical examination.6 Two other cases of S. pyogenes peritonitis in adult males with HIV were also reported.13 14 However, neither of our patients were immunosuppressed, and further studies should look into immunosuppression related risk factors for developing S. pyogenes peritonitis.

Finally, preceding varicella infection was seen in 13% and 15% of paediatric invasive S. pyogenes infections in national surveys of Canada and Finland, respectively.6 15 Although the authors did not propose a reason why this association exists, the viral infection may simply act as a nidus for haematogenous spread.6 While 15% of patients identified in our literature review had a rash, dermatologic findings can be associated with toxic shock syndrome, varicella infection or other aetiologies. Additionally, it was not always clear whether this symptom preceded or was secondary to the infection. Finally, neither of our patients had a rash during the course of their illness. Thus, we feel that the presence or absence of a rash is not helpful in identifying patients with S. pyogenes peritonitis.

The therapy for S. pyogenes varies based on the tissue affected and the clinical presentation. The choice of antibiotics provided to the patient varied in our literature review, but generally included broad spectrum beta-lactam antibiotics. However, invasive S. pyogenes infections are best treated with combination therapy including clindamycin and beta-lactam antibiotics16 as monotherapy with beta-lactam has been associated with increased mortality.17 The decreased efficacy of beta-lactam monotherapy was initially described as the ‘Eagle effect’ and recent studies have shown antibiotics that work at the ribosomal level are important in the management of invasive S. pyogenes.17 18

Conclusion

The incidence of invasive S. pyogenes infection has increased significantly over the last decade. We reviewed 32 total cases of S. pyogenes peritonitis, including two treated at our own institution. Female gender, immunosuppression and preceding varicella infection have been suggested as possible risk factors for developing S. pyogenes peritonitis. Female gender predominated in the literature; however, the exact mechanism remains evasive. Nevertheless, the essential components of managing this patient population effectively include awareness, early suspicion and early initiation of appropriate antibiotic therapy.

Learning points.

  • Streptococcus pyogenes can cause invasive disease including primary peritonitis.

  • Keys to the management of S. pyogenes infection include awareness and early initiation of appropriate antibiotics.

Footnotes

Contributors: MT, AB and MJ: the conception and design of the study, or acquisition of data, or analysis and interpretation of data. MT, AB, MJ and ET: drafting the article or revising it critically for important intellectual content and final approval of the version to be submitted.

Funding: The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

Competing interests: None declared.

Provenance and peer review: Not commissioned; externally peer reviewed.

Patient consent for publication: Obtained.

References

  • 1. Stevens DL. Invasive Group A Streptococcus Infections. Clin Infect Dis 1992. [DOI] [PubMed] [Google Scholar]
  • 2. : Ferretti JJ, Stevens DL, Fischetti VA,  Streptococcus pyogenes : Basic Biology to Clinical Manifestations.  Oklahoma City (OK: University of Oklahoma Health Sciences Center, 2016. [PubMed] [Google Scholar]
  • 3. Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report Emerging Infections Program Network, Group A Streptococcus. 2012. [Google Scholar]
  • 4. Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network Group A Streptococcus, 2015. [Google Scholar]
  • 5. Westwood DA, Roberts RH. Management of Primary Group A Streptococcal Peritonitis: A Systematic Review. Surg Infect 2013;14:171–6. 10.1089/sur.2012.038 [DOI] [PubMed] [Google Scholar]
  • 6. Tapiainen T, Launonen S, Renko M, et al. Invasive Group A Streptococcal Infections in Children: A Nationwide Survey in Finland. Pediatr Infect Dis J 2016. [DOI] [PubMed] [Google Scholar]
  • 7. Kimber CP, Hutson JM. PRIMARY PERITONITIS IN CHILDREN. ANZ J Surg 1996;66:169–70. 10.1111/j.1445-2197.1996.tb01149.x [DOI] [PubMed] [Google Scholar]
  • 8. Lamagni TL, Darenberg J, Luca-Harari B, et al. Strep-EURO Study Group. Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 2008;46:2359–67. 10.1128/JCM.00422-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Nelson GE, Pondo T, Toews KA, et al. Epidemiology of Invasive Group A Streptococcal Infections in the United States, 2005-2012. Clin Infect Dis 2016;63:478–86. 10.1093/cid/ciw248 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Meehan M, Murchan S, Bergin S, et al. Increased incidence of invasive group A streptococcal disease in Ireland, 2012 to 2013. Euro Surveill 2013;18:20556 10.2807/1560-7917.ES2013.18.33.20556 [DOI] [PubMed] [Google Scholar]
  • 11. Elniel M, Grainger J, Nevins EJ, et al. 72 h Is the Time Critical Point to Operate in Acute Appendicitis. J Gastrointest Surg 2018;22:310–5. 10.1007/s11605-017-3614-8 [DOI] [PubMed] [Google Scholar]
  • 12. Dann PH, Amodio JB, Rivera R, et al. Primary bacterial peritonitis in otherwise healthy children: imaging findings. Pediatr Radiol 2005;35:198–201. 10.1007/s00247-004-1304-7 [DOI] [PubMed] [Google Scholar]
  • 13. Zazzo JF, Troche G, Millat B, et al. Phlegmonous gastritis associated with HIV-1 seroconversion. Endoscopic and microscopic evolution. Dig Dis Sci 1992;37:1454–9. [DOI] [PubMed] [Google Scholar]
  • 14. Abraham G. Streptococcus pyogenes peritonitis associated with genital swelling and gastroenteritis caused by Cryptosporidium and Salmonella paratyphi B in an HIV infected patient on CAPD. Nephrol. Dial. Transplant 1995;10:140–1. [PubMed] [Google Scholar]
  • 15. Laupland KB, Davies HD, Low DE, et al. Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Ontario Group A Streptococcal Study Group. Pediatrics 2000;105:E60. [DOI] [PubMed] [Google Scholar]
  • 16. Zimbelman J, Palmer A, Todd J. Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr Infect Dis J 1999;18:1096–100. 10.1097/00006454-199912000-00014 [DOI] [PubMed] [Google Scholar]
  • 17. Eagle H. Experimental approach to the problem of treatment failure with penicillin. I. Group A streptococcal infection in mice. Am J Med 1952;13:389–99. [DOI] [PubMed] [Google Scholar]
  • 18. Stevens DL, Gibbons AE, Bergstrom R, et al. The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J Infect Dis 1988;158:23–8. 10.1093/infdis/158.1.23 [DOI] [PubMed] [Google Scholar]
  • 19. Woods CR, Mason CS. Primary group A streptococcal peritonitis in a human immunodeficiency virus-infected patient. Pediatr Infect Dis J 1997;16:1185–6. 10.1097/00006454-199712000-00019 [DOI] [PubMed] [Google Scholar]
  • 20. Moskovitz M, Ehrenberg E, Grieco R, et al. Primary peritonitis due to group A streptococcus. J Clin Gastroenterol 2000;30:332–5. 10.1097/00004836-200004000-00030 [DOI] [PubMed] [Google Scholar]
  • 21. Tufariello JM, Kaleya RN, Klein RS. Group A streptococcal appendicitis in a patient with AIDS. Diagn Microbiol Infect Dis 2000;38:171–2. 10.1016/S0732-8893(00)00188-7 [DOI] [PubMed] [Google Scholar]
  • 22. Sanchez NC, Lancaster BA. A rare case of primary group A streptococcal peritonitis. Am Surg 2001;67:633–4. [PubMed] [Google Scholar]
  • 23. Gillespie RS, Hauger SB, Holt RM. Primary group A streptococcal peritonitis in a previously healthy child. Scand J Infect Dis 2002;34:847–8. 10.1080/0036554021000026944 [DOI] [PubMed] [Google Scholar]
  • 24. Kanetake K, Hayashi M, Hino A, et al. Primary peritonitis associated with streptococcal toxic shock-like syndrome: report of a case. Surg Today 2004;34:1053–6. 10.1007/s00595-004-2863-9 [DOI] [PubMed] [Google Scholar]
  • 25. Dumas F, Kierzek G, Coignard S, et al. Acute appendicitis, an unusual presentation of Streptococcus pyogenes infection. Am J Emerg Med 2009;27:254.e1–254.e2. 10.1016/j.ajem.2008.06.029 [DOI] [PubMed] [Google Scholar]
  • 26. Sewrey H, Bryant PA. Group A streptococcus causing primary peritonitis in a healthy infant. Pediatr Infect Dis J 2009;28:1146 10.1097/INF.0b013e3181bdbd9f [DOI] [PubMed] [Google Scholar]
  • 27. Tilanus AM, de Geus HR, Rijnders BJ, et al. Severe group A streptococcal toxic shock syndrome presenting as primary peritonitis: a case report and brief review of the literature. Int J Infect Dis 2010;14 Suppl 3(Suppl 3):e208–e212. 10.1016/j.ijid.2009.07.014 [DOI] [PubMed] [Google Scholar]
  • 28. Saha P, Morewood T, Naftalin J, et al. Acute abdomen in a healthy woman: primary peritonitis due to group A streptococcus. J Obstet Gynaecol 2006;26:700–1. 10.1080/01443610600940232 [DOI] [PubMed] [Google Scholar]
  • 29. Haap M, Haas CS, Teichmann R, et al. Mystery or misery? Primary group A streptococcal peritonitis in women: case report. Am J Crit Care 2010;19:454–8. 10.4037/ajcc2009615 [DOI] [PubMed] [Google Scholar]
  • 30. Legras A, Lodico R, Ferre R, et al. Primary peritonitis due to Streptococcus A: laparoscopic treatment. J Visc Surg 2011;148:e315–e317. 10.1016/j.jviscsurg.2011.07.002 [DOI] [PubMed] [Google Scholar]
  • 31. Demitrack J. Primary group A streptococcal peritonitis in a previously healthy child. Pediatr Infect Dis J 2012;31:542–3. 10.1097/INF.0b013e31824f1b0d [DOI] [PubMed] [Google Scholar]
  • 32. Holden R, Wilmer A, Kollman T. Primary peritonitis due to group A Streptococcus in a previously healthy pediatric patient. Can J Infect Dis Med Microbiol 2012;23:e69–e70. 10.1155/2012/105850 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Preece ER, Athan E, Watters DAK, et al. Spontaneous bacterial peritonitis: a rare mimic of acute appendicitis. ANZ J Surg 2012;82:283–4. 10.1111/j.1445-2197.2012.06007.x [DOI] [PubMed] [Google Scholar]
  • 34. Park JY, Moon SY, Son JS, et al. Unusual primary peritonitis due to Streptococcus pyogenes in a young healthy woman. J Korean Med Sci 2012;27:553–5. 10.3346/jkms.2012.27.5.553 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Cheung V, Dawis MA, Zheng M, et al. Group A streptococcal primary ileitis: a novel presentation of a common pathogen. Pediatr Infect Dis J 2013;32:1155–6. 10.1097/INF.0b013e31829aa66b [DOI] [PubMed] [Google Scholar]
  • 36. Nogami Y, Tsuji K, Banno K, et al. Case of streptococcal toxic shock syndrome caused by rapidly progressive group A hemolytic streptococcal infection during postoperative chemotherapy for cervical cancer. J Obstet Gynaecol Res 2014;40:250–4. 10.1111/jog.12126 [DOI] [PubMed] [Google Scholar]
  • 37. Patel RV, Kumar H, More B, et al. Primary group A streptococcal septic shock syndrome simulating perforated appendicitis in a previously healthy girl. Case Reports 2013;2013:bcr2013009502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Filan E, Abbas M. Abdominal Pain, Fever, and Infection Secondary to an Unusual Source in a Previously Healthy Child. Clin Pediatr 2014;53:607–9. 10.1177/0009922814526987 [DOI] [PubMed] [Google Scholar]
  • 39. Min SY, Kim YH, Park WS. Acute phlegmonous gastritis complicated by delayed perforation. World J Gastroenterol 2014;20:3383–7. 10.3748/wjg.v20.i12.3383 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Kaneko M, Maruta M, Shikata H, et al. Acute abdomen due to group A streptococcus bacteremia caused by an isolate with a mutation in the csrS gene. J Infect Chemother 2015;21:816–9. 10.1016/j.jiac.2015.06.010 [DOI] [PubMed] [Google Scholar]
  • 41. Abellán Morcillo I, González A, Selva Cabañero P, et al. Primary peritonitis by Streptococcus pyogenes. A condition as rare as it is aggressive. Rev Esp Enferm Dig 2016;108::231––2. 10.17235/reed.2016.4069/2015 [DOI] [PubMed] [Google Scholar]
  • 42. Yokoyama M, Oyama F, Ito A, et al. Streptococcal Toxic Shock Syndrome: Life Saving Role of Peritoneal Lavage and Drainage. Clin Med Insights Case Rep 2016;9:CCRep.S40217–7. 10.4137/CCRep.S40217 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Chomton M, Emeriaud G, Bidet P, et al. Group A streptococcal primary peritonitis in a healthy girl. J Paediatr Child Health 2017;53:615–6. 10.1111/jpc.13584 [DOI] [PubMed] [Google Scholar]
  • 44. Iitaka D, Ochi F, Nakashima S, et al. Treatment with antibodies against primary group A streptococcal peritonitis: A case report and a review of the literature. Medicine 2017;96:e9498 10.1097/MD.0000000000009498 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Iwata Y, Iwase S. Group A Streptococcal Peritonitis and Toxic Shock Syndrome in a Postmenopausal Woman. Intern Med 2017;56:2523–7. 10.2169/internalmedicine.8552-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Ledger TS. Streptococcus pyogenes primary peritonitis. BMJ Case Rep 2018;2018 10.1136/bcr-2017-223890 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ Case Reports are provided here courtesy of BMJ Publishing Group

RESOURCES